EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Population Pharmacokinetics of Prolonged Infusion for Meropenem: Tailoring Dosing Recommendations for Chinese Critically Ill Patients on Continuous Renal Replacement Therapy with Consideration for Renal Function

Yaru Peng, Yalan Liu, Zeneng Cheng, Qiang Zhang, Feifan Xie iD, Sucui Zhu, Sanwang Li

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s489603 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Yaru Peng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, People's Rep…. Hauptthemen laut MEDLINE: Meropenem, Anti-Bacterial Agents, Continuous Renal Replacement Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeropenemAnti-Bacterial AgentsContinuous Renal Replacement TherapyHumansCritical IllnessMaleMiddle AgedFemaleAgedInfusions, IntravenousMonte Carlo MethodDose-Response Relationship, DrugChinaAdultModels, BiologicalEast Asian People

Stichwörter der Autor:innen

continuous renal replacement therapycritically illmeropenempopulation pharmacokineticsprolonged infusion

Substanzen

MeropenemAnti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, People's Republic of China.
  • Office of Clinical Trial Institution, Department of Pharmacy, Peking University Shenzhen Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Department of Respiratory and Critical Care Medicine, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
  • Department of Nursing, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
  • Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, People's Republic of China.
  • Institute of Clinical Pharmacy, Central South University, Changsha, People's Republic of China.

ORCID-Profile: Feifan Xie

Zitieren

APA

Peng, Y., Liu, Y., Cheng, Z., Zhang, Q., Xie, F., Zhu, S., & Li, S. (2025). Population Pharmacokinetics of Prolonged Infusion for Meropenem: Tailoring Dosing Recommendations for Chinese Critically Ill Patients on Continuous Renal Replacement Therapy with Consideration for Renal Function. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s489603

Vancouver

Peng Y, Liu Y, Cheng Z, Zhang Q, Xie F, Zhu S, et al. Population Pharmacokinetics of Prolonged Infusion for Meropenem: Tailoring Dosing Recommendations for Chinese Critically Ill Patients on Continuous Renal Replacement Therapy with Consideration for Renal Function. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s489603

BibTeX
@article{Peng2025,
  author = {Peng, Yaru and Liu, Yalan and Cheng, Zeneng and Zhang, Qiang and Xie, Feifan and Zhu, Sucui and Li, Sanwang},
  title = {Population Pharmacokinetics of Prolonged Infusion for Meropenem: Tailoring Dosing Recommendations for Chinese Critically Ill Patients on Continuous Renal Replacement Therapy with Consideration for Renal Function},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s489603}
}
Kostenlos starten →